卖什么
面向AI就绪实验室的操作系统。
商业模式拆解
买家：谁掌握预算？
未核实Heads of lab automation, R&D or core facilities at pharma, biotech, hospital and research labs.
工作流：什么输入变成什么输出？
Scientists and automation engineers design workflows on the node-based LINQ Canvas or Python SDK, the scheduler runs parallel workflows across any vendor's instruments with live monitoring, and data flows to any ELN/LIMS; applications include genomics, cell culture, ELISA, LC/MS, high-throughput screening.
经济账：省了什么，怎么收费？
未核实Hardware (LINQ Bench) plus software and cloud subscription and service/support contracts; no prices published.
渠道：怎么接触到客户？
Direct sales via "Book a meeting" with automation experts; partnerships (e.g., Cellvoyant); offices in UK, US and Germany.
融资历史与报道
| 融资日期 | 轮次 | 金额 | 投资方 | 来源 |
|---|---|---|---|---|
| 2026-01-29 | C 轮 | $45M | — | news.google.com |
档案汇总自公开报道和公司官网。商业模式部分是 MaxBC 对这些材料的解读，不是已确认的事实；未知之处留空，不作猜测。 更新于 2026-10-12.